, Volume 194, Issue 2, pp 271–278 | Cite as

Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice

  • M. B. Echeverry
  • M. L. Salgado
  • F. R. Ferreira
  • C. A. da-Silva
  • E. A. Del Bel
Original Investigation



Catalepsy is a preclinical test that predicts extrapyramidal symptoms in humans. It models symptoms of acute extrapyramidal side effects induced at the beginning of antipsychotic treatment. Nitric oxide (NO) plays a role in a series of neurobiological functions underlying behavior. For example, inhibition of NO synthesis disrupts rodent exploratory behavior and induces catalepsy. Although several effects mediated by NO involve the activation of soluble guanylyl cyclase (sGC), the transduction mechanism of the catalepsy-inducing effect of NO has not yet been investigated.


The study was designed to test if intracerebroventricular (i.c.v.) microinjection of NO-sensitive inhibitors of sGC (NO-sGC) induces catalepsy in mice similar to that induced by NO synthase (NOS) inhibitors. Exploratory behavior was tested in the open field. In addition, the effects of a NOS inhibitor on oxidative metabolites of NO were measured in the striatum.

Materials and methods

Drug effects were examined in the hanging-bar test after the following i.c.v. treatments: oxadiazolo-quinoxalin (ODQ, 30–300 nmol) or methylene blue (MB, 3–100 nmol), selective and nonselective sGC inhibitors, respectively, or 7-nitroindazole (7-NI, 3–90 nmol) and G-nitro-l-arginine methyl ester (l-NAME, 3–90 nmol), selective and nonselective neuronal NOS inhibitors. To test if the effects were related to interference with the NO system, additional groups received 7-NI (30 nmol), ODQ (100 nmol), or L-NAME (90 nmol) preceded by l-arginine (l-arg, 30–100 nmol, i.c.v. 30 min before). A possible interference of ODQ and 7-NI on exploratory behavior was tested in an open field. The concentration of nitrites and nitrates (NO x ) in striatum homogenates was measured by the Griess reaction.


Both NO-sGC and NOS inhibitors induced catalepsy in mice that lasted for at least 2 h. The range of effective doses of these drugs, however, was limited, and the dose–effect curves had an inverted U shape. The cataleptic effect induced by l-NAME was inversely correlated with NO x products in the striatum. The cataleptic effect of 7-NI and ODQ was prevented by pretreatment with l-arginine. No drug changed exploratory behavior in the open field.


This study showed that pharmacological disruption of the endogenous NO-sGC signaling in the central nervous system induces long-lasting catalepsy in mice. Moreover, the cataleptic effect of NOS inhibition correlates with the decrease in NO x products formation in the striatum. The results give further support to the hypothesis that NO plays a role in motor behavior control mediated, at least in part, by cyclic guanosine monophosphate production in the striatum.


Nitric oxide Catalepsy L-arginine 7-nitroindazole l-NAME ODQ Intracerebroventricular Methyl blue Open-field test Nitrate Nitrite Nitrogen oxides 





one-way analysis of variance


3′-5′-cyclic adenosine monophosphate


cyclic guanosine monophosphate




dimethyl sulfoxide






NG-nitro-l-arginine methyl ester hydrochloride


multivariate analysis of variance


methyl blue


N-methyl d-aspartate


neuronal nitric oxide synthase isoform


nitric oxide






nitric oxide-sensitive soluble guanylyl cyclases


nitric oxide synthase


nitrogen oxides




soluble guanylyl cyclase



The authors acknowledge the helpful technical support provided by S. Saltareli, P. Marchi, G. Bertozi-Francisco and R. Ferreira-da-Silva. We thank our coworker L.P. Nucci-da-Silva who participated in some of the experiments described in this manuscript. We are in debt to Prof. F.S. Guimarães for manuscript discussion and suggestions. The study was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).


  1. Abekawa T, Ohinori T, Koyama T (1994) Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine. Brain Res 666:147–150PubMedCrossRefGoogle Scholar
  2. Ariano MA (1983) Distribution of components of the guanosine 3′,5′-phosphate system in rat caudate-putamen. Neurosci 10:707–723CrossRefGoogle Scholar
  3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRefGoogle Scholar
  4. Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030–9033PubMedCrossRefGoogle Scholar
  5. Chaparro-Huerta V, Beas-Zarate C, Guerrero MU, Feria-Velasco A (1997) Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain. Neurochem Int 31:607–616PubMedCrossRefGoogle Scholar
  6. Coderre TJ (1994) The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol Neurobiol 7:229–246Google Scholar
  7. Contestabile A (2000) Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res Rev 32:476–509PubMedCrossRefGoogle Scholar
  8. Dall’Igna OP, Dietrich MO, Hoffmann A, Neto W, Vendite D, Souza DO, Lara DR (2001) Catalepsy and hypolocomotion induced by nitric oxide donor: attenuation by theophyline. Eur J Pharmacol 432:29–33PubMedCrossRefGoogle Scholar
  9. Del Bel EA, Guimarães FS (2000) Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice. Psychopharmacology 147:356–361PubMedCrossRefGoogle Scholar
  10. Del Bel EA, Souza AS, Guimarães FS, da-Silva CA, Nucci-da-Silva LP (2002) Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice. Psychopharmacology 161:32–37PubMedCrossRefGoogle Scholar
  11. Del Bel EA, da Silva CA, Guimarães FS, Bermudez-Echeverry M (2004) Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats. Eur J Pharmacol 485:175–181PubMedCrossRefGoogle Scholar
  12. Del Bel EA, Guimarães FS, Bermudez-Echeverry M, Gomes MZ, Schiaveto-de-souza A, Padovan-Neto FE, Tumas V, Barion-Cavalcanti AP, Lazzarini M, Nucci-da-Silva LP, de Paula-Souza D (2005) Role of nitric oxide on motor behavior. Cell Mol Neurobiol 25:371–392PubMedCrossRefGoogle Scholar
  13. Demas GE, Kriegsfeld LJ, Blackshaw S, Huang P, Gammie SC, Nelson RJ, Snyder SH (1999) Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J Neurosci 19:C1–C5Google Scholar
  14. Dere E, De Souza Silva MA, Topic B, Fiorillo C, Li J-S, Sadile AG, Frisch C, Huston JP (2002) Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav 1(4):204–213PubMedCrossRefGoogle Scholar
  15. Eroglu L, Caglayan B (1997) Anxiolytic and antidepressant properties of Methylene blue in animal models. Pharmacol Res 36:381–385PubMedCrossRefGoogle Scholar
  16. Esplugues JV (2002) NO as a signalling molecule in the nervous system. Br J Pharmacol 135:1079–1095PubMedCrossRefGoogle Scholar
  17. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates, 2nd edn. Academic, New YorkGoogle Scholar
  18. Greenberg JH, Hamada J, Rysman K (1997) Distribution of Nω-nitro-L-arginine following topical and intracerebroventricular administration in the rat. Neurosci Lett 229:1–4PubMedCrossRefGoogle Scholar
  19. Guevara I, Iwanejko J, Dembinska-Kiec A, Pankiewicz J, Wanat A, Anna P, Golabek I, Bartus S, Malczewska-Malec M, Szczudlik A (1998) Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 274(2):177–188PubMedCrossRefGoogle Scholar
  20. Guimarães FS, Beijamini V, Moreira FA, Aguiar DC, Lucca AC (2005) Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 29:1313–1322PubMedCrossRefGoogle Scholar
  21. Harvey BH (1996) Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness. Hum Psychopharmacol 11:309–319CrossRefGoogle Scholar
  22. Harvey BH, Bester A (2000) Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatment. Behav Brain Res 111:203–211PubMedCrossRefGoogle Scholar
  23. Hecker M, Mitchell JA, Harris HJ, Katsura M, Thiemermann C, Vane JR (1990) Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun 167:1037–1043PubMedCrossRefGoogle Scholar
  24. Hu J, Lee JH, El-Fakahany EE (1994) Inhibition of neuronal nitric oxide synthase by antipsychotic drugs. Psychopharmacology (Berl) 114:161–166CrossRefGoogle Scholar
  25. Itzhak Y, Martin JL (2002) Effect of the neuronal nitric oxide synthase inhibitor 7-nitroindazole on methylphenidate-induced hyperlocomotion in mice. Behav Pharmacol 3(1):81–86Google Scholar
  26. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, Scheeren T, Godecke A, Schrader J, Schulz R, Heusch G, Schaub GA, Bryan NS, Feelisch M, Kelm M (2003) Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35(7):790–796PubMedCrossRefGoogle Scholar
  27. Klemm WR (1985) Experimental catalepsy is both enhanced and disrupted by apomorphine. Psychopharmacology (Berl) 87:12–15CrossRefGoogle Scholar
  28. Kriegsfeld LJ, Eliasson MJ, Demas GE, Blackshaw S, Dawson TM, Nelson RJ, Snyder SH (1999) Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice. Neuroscience 89:311–315PubMedCrossRefGoogle Scholar
  29. Lino de Oliveira C, Del Bel EA, Guimarães FS (1997) Effects of L-NOARG on plus-maze performance in rats. Pharmacol Biochem Behav 56:55–59CrossRefGoogle Scholar
  30. Manzanedo C, Aguilar MA, Rodríguez-Arias M, Navarro M, Miñarro J (2004) 7-Nitroindazole blocks conditioned place preference but not hyperactivity induced by morphine. Behav Brain Res 150:73–82PubMedCrossRefGoogle Scholar
  31. Marras R, Martins AP, Del Bel EA, Guimarães FS (1995) L-NOARG, an inhibitor of nitric oxide synthase induces catalepsy in mice. NeuroReport 7:158–160PubMedGoogle Scholar
  32. Masaki E, Kondo I (1999) Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats. Anesth Analg 89:484–490CrossRefGoogle Scholar
  33. Miki N, Kawabe Y, Kuriyama K (1977) Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun 75:851–856PubMedCrossRefGoogle Scholar
  34. Miquel M, Aguilar MA, Aragon CM (1999) Ascorbic acid antagonizes ethanol-induced locomotor activity in the open-field. Pharmacol Biochem Behav 62:361–366PubMedCrossRefGoogle Scholar
  35. Moore PK, Handy RL (1997) Selective inhibitors of neuronal nitric oxide synthase—is no NOS really good NOS for the nervous system. Trends Pharmacol Sci 18:204–211PubMedGoogle Scholar
  36. Nelson R, Demas G, Huang P, Fishman M, Dawson V, Dawson T, Snyder S (1995) Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378:383–386PubMedCrossRefGoogle Scholar
  37. Nicholson C (1999) Signals that go with the flow. Trends Neurosci 22(4):143–145CrossRefGoogle Scholar
  38. Noda Y, Yamada K, Furukawa H, Nabeshima T (1995) Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur J Pharmacol 286:291–297PubMedCrossRefGoogle Scholar
  39. Nucci-da-Silva LP, Guimarães FS, Del Bel EA (1999) Serotonin modulation of catalepsy induced by N(G)-nitro-L-arginine in mice. Eur J Pharmacol 379:47–52PubMedCrossRefGoogle Scholar
  40. Sancesario G, Morello M, Reiner A, Giacomini P, Massa R, Schoen S, Bernardi G (2000) Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide. Neuroscience 99:627–642PubMedCrossRefGoogle Scholar
  41. Segieth J, Gerring SJ, Biggs CS, Whitton PS (1995) Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats. Neurosci Lett 200:101–104PubMedCrossRefGoogle Scholar
  42. Segieth J, Fowler L, Whitton P, Pearce B (2000) Nitric oxide-mediated regulation of dopamine release in the hippocampus in vivo. Neuropharmacology 39:571–577PubMedCrossRefGoogle Scholar
  43. Silva MT, Rose S, Hindmarsh JG, Jenner P, Marsden CD (1997) L-Arginine produces NO-independent increases in dopamine efflux in rat striatum. NeuroReport 9:149–152CrossRefGoogle Scholar
  44. Siuciak JA, Chapin DS, Harms JF, Lebel LA, McCarthy SA, Chambers L, Shrikhande A, Wong S, Menniti FS, Schmidt CJ (2006) Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis. Neuropharmacology 51:386–396PubMedCrossRefGoogle Scholar
  45. Trabace L, Kendrick KM (2000) Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J Neurochem 75:1664–1674PubMedCrossRefGoogle Scholar
  46. Tsikas D (2005) Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 39(8):797–815PubMedCrossRefGoogle Scholar
  47. Vincent SR, Kimura H (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neurosci 46:755–784CrossRefGoogle Scholar
  48. Weitzdoerfer R, Hoeger H, Engidawork E, Engelmann M, Singewald N, Lubec G, Lubec B (2004) Neuronal nitric oxide synthase knockout mice show impaired cognitive performance. Nitric Oxide 10(3):130–140PubMedCrossRefGoogle Scholar
  49. Wennmalm Å, Benthin G, Petersson AS (1992) Dependence of the metabolism of nitric oxide in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 106:507–508PubMedGoogle Scholar
  50. West AR, Galloway MP, Grace AA (2002) Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44:227–245PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • M. B. Echeverry
    • 1
  • M. L. Salgado
    • 1
  • F. R. Ferreira
    • 2
  • C. A. da-Silva
    • 1
  • E. A. Del Bel
    • 1
  1. 1.Department MEF—Physiology, FORPUniversity of Sao PauloRibeirão PretoBrazil
  2. 2.Department of Pharmacology, FMRPUniversity of Sao PauloRibeirão PretoBrazil

Personalised recommendations